Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection-Reference-Cited by-同舟云学术

Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection

Published:2015-09-30 Issue:5 Volume:46 Page:489-491
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Takayama Hiroki¹,Sato Takeshi¹,Ikeda Fusao²,Fujiki Shigeatsu¹

Affiliation:

1. Department of Gastroenterology; Tsuyama Central Hospital; Tsuyama Japan

2. Department of Gastroenterology and Hepatology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12578/fullpdf

Reference9 articles.

1. European Association for the Study of the Liver;EASL Recommendations on Treatment of Hepatitis C;J Hepatol,2015

2. JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1;Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology;Hepatol Res,2014

3. Daclatasvir plus asnaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014

4. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial;Mizokami;Lancet Infect Dis,2015

5. JSH Guidelines for the Management of Hepatitis B Virus Infection;Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology;Hepatol Res.,2014

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment;Life;2023-09-26

2. Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy;Scientific Reports;2022-10-07

3. Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt;Journal of Clinical and Experimental Hepatology;2022-09

4. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31

5. HBsAg Loss Due to Tenofovir Treatment for HBV Reactivation Following DAAs Therapy in One Patient with HBV-HCV Coinfection;Infectious Diseases & Immunity;2021-05-27